These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 25211919)

  • 1. [Characteristics of lipid peroxidation and activity of sympathetic nervous system in patients with chronic calculous pyelonephritis].
    Oskolkov SA; Zhmurov VA; Tverdoĭ VE; Arshakian GG; Zhmurov DV; Siniaev EA
    Urologiia; 2014; (3):8-12. PubMed ID: 25211919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative effectiveness of fluoroquinolones and beta-lactams in the complex therapy of patients with chronic pyelonephritis].
    Tverdoĭ VE; Oskolkov SA; Zhmurov VA; Petrova IuA; Oborotova NV
    Urologiia; 2012; (4):8-12. PubMed ID: 23116015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Essential phospholipids in the treatment of chronic pyelonephritis].
    Ovchinnikov AA; Tsvettsikh VE; Berdichevskiĭ BA; Lykov VN; Suktanbaev VR; Murychev AV
    Urol Nefrol (Mosk); 1996; (4):7-9. PubMed ID: 8928353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid peroxidation in patients with nephrolithiasis and chronic pyelonephritis in the remission stage].
    Golovanov SA; Drozhzheva VV
    Urol Nefrol (Mosk); 1995; (2):21-2. PubMed ID: 7785114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structural-functional damage to cellular membranes in deficiency of vitamins A, E, B2, B6, PP in children with calculous pyelonephritis].
    Atadzhanov UZh; Utegenov NU
    Urologiia; 2003; (1):35-41. PubMed ID: 12621965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipid peroxidation in the kidney tissue of patients with nephrolithiasis and chronic pyelonephritis].
    Golod EA; Darenkov AF; Kirpatovskiĭ VI; Ianenko EK
    Urol Nefrol (Mosk); 1995; (5):8-10. PubMed ID: 8571492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipid peroxidation and Ca-dependent ATPase activity in the microsomal fraction of renal tissue in patients with nephrolithiasis and chronic pyelonephritis].
    Golod EA
    Urol Nefrol (Mosk); 1996; (5):14-6. PubMed ID: 9054096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipids content in renal tissue membranes in patients with urolithiasis and secondary pyelonephritis].
    Kazeko NI; Zhmurov VA; Borovskiĭ AA; Veshkurtsev VV; Khvan OV
    Urologiia; 2005; (5):56-8. PubMed ID: 16281843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [State of the sympathetic-adrenal system and aldosterone excretion in children with urolithiasis, pyelonephritis and chronic renal insufficiency].
    Abdullaev KI; Mamedova IaA
    Urol Nefrol (Mosk); 1977; (6):21-4. PubMed ID: 929779
    [No Abstract]   [Full Text] [Related]  

  • 10. [Polyoxidonium in the treatment of calculous pyelonephritis].
    Kazeko NI; Zhmurov VA; Borovskiĭ AA; Lerner GIa; Katrenko IV; Nechaĭ EN; Shmelev PA
    Urologiia; 2006; (2):59-62. PubMed ID: 16708592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disturbances of lipid exchange and peroxidation system in patients with chronic pyelonephritis].
    Rudichenko EV; Antoniuk MV; Gvozdenko TA
    Klin Med (Mosk); 2006; 84(5):54-8. PubMed ID: 16827282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The indices of cell membrane destabilization in urolithiasis patients].
    Zhmurov VA; Kazeko NI; Lerner GIa; Tsvettsikh VE; Sultanbaev VR
    Urol Nefrol (Mosk); 1991; (3):12-5. PubMed ID: 1871916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antioxidant and membranoprotector treatment of chronic pyelonephritis].
    Gordiushina IV; Savchenko RP; Sukhanov DS; Petrov AIu; Romantsov MG
    Eksp Klin Farmakol; 2011; 74(4):27-30. PubMed ID: 21678656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-biochemical and morphological changes in obstructive calculous pyelonephritis in children].
    Akylbaev DD; Nikolaev AI; Sulaĭmanov AS; Mamutov ZhI; Islambekov GK
    Vestn Khir Im I I Grek; 1986 Oct; 137(10):86-8. PubMed ID: 3798672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diurnal rhythm of catecholamine excretion and reactivity of the symphathetic-adrenal system in patients with chronic pyelonephritis].
    Karpenko EI; Kamyshan IS
    Sov Med; 1974 Mar; 37(3):116-9. PubMed ID: 4846967
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biochemical characteristics and treatment of chronic pyelonephritis in the clinical remissions phase].
    Lopatkin NA; Chudnovskaia MV; Nenasheva NP; Rodoman VE; Ginis IV
    Urol Nefrol (Mosk); 1978; (2):3-7. PubMed ID: 644716
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinicobiochemical and immunological assessment of polyoxidonium efficacy in the treatment of patients with chronic calculous pyelonephritis].
    Kazeko NI; Khil'kevich SV
    Urologiia; 2011; (6):20, 22-5. PubMed ID: 22448475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The activity of lipid peroxidation processes and the status of the neurohumoral regulation mechanisms in patients with chronic pyelonephritis].
    Tsvettsikh VE; Krylov VI; Lerner GIa; Zhmurov VA; Kazko NI; Ovchinnikov AA; Sultanbaev VR; Emel'ianov GP
    Ter Arkh; 1992; 64(11):80-2. PubMed ID: 1363450
    [No Abstract]   [Full Text] [Related]  

  • 19. [The dynamic level of beta 2-microglobulin, the basic lipid peroxidation indices and middle molecules in the blood and urine in patients with acute calculous pyelonephritis against a background of endovascular helium-neon laser therapy].
    Safafov RM; Ianenko EK; Nikitinskaia LP; Golovanov SA; Drozhzheva VV; Kon'kova TA; Danilkov AP
    Urol Nefrol (Mosk); 1997; (1):11-3. PubMed ID: 9123656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rehabilitation of the patients suffering from chronic calculous pyelonephritis].
    Tret'iakov AA; Kaĭsinova AS; Mishchenko MM; Uzdenov MA
    Vopr Kurortol Fizioter Lech Fiz Kult; 2012; (3):19-22. PubMed ID: 23113363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.